Two 2-oxo-3-phenylpropionic acid arylformylhydrazone dibenzyltin(IV)complexes{[C4H3O(O)C=N-N=C(PhCH2)COO](C6H5CH2)2Sn(CH3OH)}2(Ⅰ)and{[t-Bu-C6H4(O)C=N-N=C(PhCH2)COO](C6H5CH2)2Sn(CH3OH)}2(Ⅱ)have been synthesized and c...Two 2-oxo-3-phenylpropionic acid arylformylhydrazone dibenzyltin(IV)complexes{[C4H3O(O)C=N-N=C(PhCH2)COO](C6H5CH2)2Sn(CH3OH)}2(Ⅰ)and{[t-Bu-C6H4(O)C=N-N=C(PhCH2)COO](C6H5CH2)2Sn(CH3OH)}2(Ⅱ)have been synthesized and characterized by IR,1H,13C and 119Sn NMR spectra,HRMS,and elemental,thermal stability and single-crystal X-ray diffraction analyses.Complex I crystallizes in the triclinic system,space group P1 with a=9.0392(9),b=10.249(1),c=15.5762(15)?,α=98.605(1)°,β=103.765(1)°,γ=104.056(1)°,Z=2,V=1326.3(2)?3,Dc=1.511 Mg·m^–3,m(MoKa)=1.005 mm–1,F(000)=612,R=0.0206 and wR=0.0524.Complex Ⅱ belongs to triclinic system,space group P1,a=11.4643(3),b=11.8885(3),c=13.0362(4)?,α=73.800(1)°,β=71.679(1)°,γ=79.006(1)°,Z=2,V=1609.34(8)?3,Dc=1.381 Mg·m^–3,m(MoKa)=0.833 mm–1,F(000)=688,R=0.0244 and wR=0.0244.In vitro antitumor activities of both complexes were evaluated by MTT against three human cancer cell lines(NCI-H460,HepG2 and MCF7)and human cell lines(HL7702).Both complexes exhibit better antitumor activity.Furthermore,the interaction between both complexes and calf thymus DNA was studied with EB fluorescent probe.展开更多
Two dibenzyltin compounds,{[C6H5O(O)C=N-N=C(Ph)COO](m-Cl-C6H4CH2)2-Sn(CH3OH)}2(1)and{[p-Me-C6H4O(O)C=N-N=C(Ph)COO](m-Cl-C6H4CH2)2Sn(CH3OH)}2(2),have been synthesized by microwave“one pot”reaction with benzoylhydrazi...Two dibenzyltin compounds,{[C6H5O(O)C=N-N=C(Ph)COO](m-Cl-C6H4CH2)2-Sn(CH3OH)}2(1)and{[p-Me-C6H4O(O)C=N-N=C(Ph)COO](m-Cl-C6H4CH2)2Sn(CH3OH)}2(2),have been synthesized by microwave“one pot”reaction with benzoylhydrazine(or p-methyl benzhydrazine),phenylglyoxylic acid and di-m-chlorobenzyltin dichloride.Compound 2 contains two crystals 2a and 2b.The compounds have been characterized with IR,elemental analysis,1H,13C and 119Sn NMR spectra,H RMS.Three crystals are all binuclear molecules with a Sn2O2 four-membered ring plane,and each Sn atom center is seven-coordinated with[SnO4C2N]to form a distorted pentagonal bipyramidal configuration.In vitro antitumor activities of all compounds and carboplatin were evaluated by MTT against three human cancer cells such as NCI-H460(lung cancer cells),HepG2(liver cancer cells)and MCF7(breast cancer cells),and compound 2 exhibited better antitumor activity.展开更多
Diorganotin 2-(2-(4-methoxybenzoyl)hydrazono)-3-phenylpropanoic carboxylate complexes Ⅰ{[p-CH3 O-C6 H4 O(O)C=N-N=C(Ph CH2)COO](n-Bu)2 Sn(CH3 OH)}2 and Ⅱ {[p-CH3 O-C6 H4 O(O)C=NN=C(Ph CH2)COO](Ph CH2)2 Sn(CH3 OH)}2 h...Diorganotin 2-(2-(4-methoxybenzoyl)hydrazono)-3-phenylpropanoic carboxylate complexes Ⅰ{[p-CH3 O-C6 H4 O(O)C=N-N=C(Ph CH2)COO](n-Bu)2 Sn(CH3 OH)}2 and Ⅱ {[p-CH3 O-C6 H4 O(O)C=NN=C(Ph CH2)COO](Ph CH2)2 Sn(CH3 OH)}2 have been synthesized. The complexes have been characterized by IR, 1 H, 13 C and 119 Sn NMR spectra, HRMS, elemental analysis, thermal stability analysis and the crystal structures have been determined by X-ray diffraction. The crystal of complex I belongs to triclinic system, space group P1 with a = 10.437(2), b = 11.576(3), c = 13.085(3) ?, α = 66.272(2)°, β = 86.920(3)°, γ = 73.367(3)°, Z = 2, V = 1383.3(5) ?3, Dc = 1.381 Mg·m-3, m(Mo Kα) = 0.959 mm-1, F(000) = 592, R = 0.0233 and w R = 0.0644. The crystal of complex Ⅱ is of triclinic system, space group P1 with a = 10.446(1), b = 11.720(1), c = 13.063(2) ?, α = 84.190(1)°, β = 71.610(1)°, γ = 72.624(1)°, Z = 1, V = 1448.3(3) ?3, Dc = 1.475 Mg·m-3, m(Mo Kα) = 0.925 mm-1, F(000) = 656, R = 0.0169 and w R = 0.0432. In vitro antitumor activities of both complexes were evaluated by MTT against three human cancer cell lines(NCI-H460, Hep G2 and MCF7), and two complexes exhibited good antitumor activity. The interaction between complex Ⅰ and calf thymus DNA were studied by UV-vis and fluorescence spectroscopy, the interaction of complex Ⅰ with calf thymus DNA were intercalation.展开更多
Schiff base pyridine zinc(II)complexes 1~4 were synthesized by the reaction of the 2-((2-hydroxybenzylidene)amino)phenol Schiff base with appended donor functionality,zinc acetate,and pyridine.The results of the struc...Schiff base pyridine zinc(II)complexes 1~4 were synthesized by the reaction of the 2-((2-hydroxybenzylidene)amino)phenol Schiff base with appended donor functionality,zinc acetate,and pyridine.The results of the structural characterization of the complex show that they have the same coordination mode and similar steric structure.Complexes 1 and 3 form a one-dimensional chain structure and two-dimensional grid struc-ture by lots of hydrogen bonds,respectively.Thermogravimetric analysis shows complexes 1~4 can exist stably be-low 150℃.The results of the fluorescence quenching experiments between the complexes and DNA-EB show that the interaction between them is intercalation,and the effect of complex 1 is the most obvious.It is speculated that the steric hindrance of complex 1 is relatively small,and the aromatic ring on the ligand is more likely to inserted into the base pair of DNA.展开更多
Dibutyltin benzoin benzoyl hydrazone complex Ⅰ[C_(6)H_(5)(O)C=N-N=C(Ph)CH(Ph)O]_(2)[(n-Bu)_(2)Sn]_(2)and dibutyltin benzoin salicyl hydrazone complex Ⅱ[2-(OH)-C_(6)H_(4)(O)C=N-N=C(Ph)CH(Ph)O]_(2)[(n-Bu)_(2)Sn]_(2)we...Dibutyltin benzoin benzoyl hydrazone complex Ⅰ[C_(6)H_(5)(O)C=N-N=C(Ph)CH(Ph)O]_(2)[(n-Bu)_(2)Sn]_(2)and dibutyltin benzoin salicyl hydrazone complex Ⅱ[2-(OH)-C_(6)H_(4)(O)C=N-N=C(Ph)CH(Ph)O]_(2)[(n-Bu)_(2)Sn]_(2)were synthesized and characterized by IR,^(1)H,^(13)C and^(119)Sn NMR spectra,HRMS,elemental analysis and thermal stability analysis,and the crystal structures were determined by X-ray diffraction.The crystal of complex I belongs to monoclinic system,space group P2_(1)/n with a=11.1942(8),b=10.4754(7),c=23.6700(17)?,?=101.529(2)?,Z=2,V=2719.6(3)?^(3),D_(c)=1.371 Mg·m^(–3),?(Mo Kα)=0.966 mm^(–1),F(000)=1152,R=0.0458and w R=0.1312.The crystal of complex II is of triclinic system,space group P1 with a=9.9960(4),b=11.2466(4),c=14.0509(5)?,α=69.4190(10)?,?=70.0600(10)?,γ=81.8090(10)?,Z=1,V=1389.69(9)?^(3),D_(c)=1.380 Mg·m^(–3),?(Mo Kα)=0.950 mm^(–1),F(000)=592,R=0.0284 and w R=0.0690.In vitro antitumor activities of both complexes were evaluated by CCK8 method against three human cancer cell lines(MCF7,NCI-H460 and Hep G2),and complex II exhibited better antitumor activity than I.The interaction between complexes and calf thymus DNA was studied by UV-vis,fluorescence spectroscopy and viscosity measurements.展开更多
Di-2,4-dichlorobenzyltin-2-(2-(thiophen-2-formyl)hydrazono)-propanoic carboxylate complex I{[C_(4)H_(3)S(O)C=N-N=C(CH_(3))COO]_(2)[(2,4-Cl_(2)-C_(6)H_(3)CH_(2))_(2)Sn]_(2)(CH_(3)OH)_(2)}and di-2,4-dichlorobenzyltin-2-...Di-2,4-dichlorobenzyltin-2-(2-(thiophen-2-formyl)hydrazono)-propanoic carboxylate complex I{[C_(4)H_(3)S(O)C=N-N=C(CH_(3))COO]_(2)[(2,4-Cl_(2)-C_(6)H_(3)CH_(2))_(2)Sn]_(2)(CH_(3)OH)_(2)}and di-2,4-dichlorobenzyltin-2-(2-(thio-phen-2-formyl)hydrazono)-3-phenylpropanoic carboxylate complexⅡ{[C_(4)H_(3)S(O)C=N-N=C(PhCH_(2))COO](2,4-Cl_(2)-C_(6)H_(3)CH_(2))_(2)Sn}n were synthesized and characterized by IR,^(1)H,^(13)C and^(119)Sn NMR spectra,HRMS,elemental analysis and thermal stability analysis,and the crystal structures were determined by X-ray diffraction.The crystal of complex I belongs to monoclinic system,space group P2_(1/n)with a=11.987(3),b=35.359(9),c=12.982(3)Å,β=103.028(5)°,Z=4,V=5361(2)Å3,Dc=1.688 Mg·m^(–3),μ(MoKα)=1.463 mm^(–1),F(000)=2704,R=0.0572 and wR=0.1423.The crystal of complexⅡis of monoclinic system,space group P2_(1/n)with a=15.5758(17),b=9.6020(10),c=19.599(2)Å,β=98.886(2)°,Z=4,V=2896.0(5)Å3,Dc=1.663 Mg·m^(–3),μ(MoKα)=1.357 mm^(–1),F(000)=1440,R=0.0341 and wR=0.0936.In vitro antitumor activities of both complexes were evaluated by MTT against three human cancer cell lines(MCF7,NCI-H460 and HepG2),and they all exhibited good antitumor activity.The interaction between complexes and calf thymus DNA was studied by UV-vis and fluorescence spectroscopy,it indicated intercalation as probable mode of interaction.展开更多
Two U0^(2+)_(2) complexes{[C_(5)H_(4)N(0)C=N-N=C(PhHPh)C=N-N=C(0)-C_(5)H_(4)N]2U02(CH30H)}(I)and{[C_(5)H_(4)N(0)ON-N=C(Ph)-(Ph)C=N-N=C(0)-C_(5)H_(4)N]2U02(C_(5)H_(4)N(0)C=N-NH_(2))}(II)were synthesized and characteriz...Two U0^(2+)_(2) complexes{[C_(5)H_(4)N(0)C=N-N=C(PhHPh)C=N-N=C(0)-C_(5)H_(4)N]2U02(CH30H)}(I)and{[C_(5)H_(4)N(0)ON-N=C(Ph)-(Ph)C=N-N=C(0)-C_(5)H_(4)N]2U02(C_(5)H_(4)N(0)C=N-NH_(2))}(II)were synthesized and characterized by IR,elemental analysis and thermal stability analysis,and the crystal structures were determined by X-ray diffraction.The crystal of complex I belongs to monoclinic system,space group P2_(1/n) with α=11.7678(4),6=16.9667(6),c=14.3051(5)A,β=98.918(3)°,Z=4,F=2821.64(17)A^(3),D_(c)=1.837 Mg·m^(-3),μ(MoKα)=5.805 mm^(-1),F(000)=1504,R=0.0346 and wR=0.0688.The crystal of complex II is of triclinic system,space group Pi with a=11.6417(5),b=11.7297(5),c=14.2197(5)A,α=71.697(4)°,β=86.020(3)°,γ=71.572(4)°,Z=2,K=1748.02(12)A^(3),D_(c)=1.742 Mg·m^(-3),μ(MoKa)=4.704 mm^(-1),F(000)=894,R=0.0283 and wR=0.0537.The U1 is a seven-coordinate pentagonal bipyramidal configuration in I and an eight-coordinate hexagonal dipyramidal configuration in II.The thermal stability and quantum chemical calculations of I and II were also investigated.展开更多
基金Supported by Hunan Provincial College Student Research Study and Innovative Experiment Project(No.cx1813)Natural Science Foundation of Hunan Province(No.2017JJ3003)+1 种基金Hengyang Normal University Discipline Group Construction Project(No.18XKQ01)Foundation of Key Laboratory of Functional Metal-organic Compounds of Hunan Province(No.MO18K01)
文摘Two 2-oxo-3-phenylpropionic acid arylformylhydrazone dibenzyltin(IV)complexes{[C4H3O(O)C=N-N=C(PhCH2)COO](C6H5CH2)2Sn(CH3OH)}2(Ⅰ)and{[t-Bu-C6H4(O)C=N-N=C(PhCH2)COO](C6H5CH2)2Sn(CH3OH)}2(Ⅱ)have been synthesized and characterized by IR,1H,13C and 119Sn NMR spectra,HRMS,and elemental,thermal stability and single-crystal X-ray diffraction analyses.Complex I crystallizes in the triclinic system,space group P1 with a=9.0392(9),b=10.249(1),c=15.5762(15)?,α=98.605(1)°,β=103.765(1)°,γ=104.056(1)°,Z=2,V=1326.3(2)?3,Dc=1.511 Mg·m^–3,m(MoKa)=1.005 mm–1,F(000)=612,R=0.0206 and wR=0.0524.Complex Ⅱ belongs to triclinic system,space group P1,a=11.4643(3),b=11.8885(3),c=13.0362(4)?,α=73.800(1)°,β=71.679(1)°,γ=79.006(1)°,Z=2,V=1609.34(8)?3,Dc=1.381 Mg·m^–3,m(MoKa)=0.833 mm–1,F(000)=688,R=0.0244 and wR=0.0244.In vitro antitumor activities of both complexes were evaluated by MTT against three human cancer cell lines(NCI-H460,HepG2 and MCF7)and human cell lines(HL7702).Both complexes exhibit better antitumor activity.Furthermore,the interaction between both complexes and calf thymus DNA was studied with EB fluorescent probe.
基金supported by the Hengyang Normal University College Students Innovation and Entrepreneurship Training Program(No.cxcy1944)Scientific Research Fund of Hunan Provincial Education Department of China(No.19C0279)+1 种基金Hengyang Normal University Industrial Supported Project(Nos.HXKJ201907,HXKJ201908,HXKJ201911,HXKJ201946,HXKJ201947)Foundation of Key Laboratory of Functional Organometallic Materials,University of Hunan Province(No.GN19K07)。
文摘Two dibenzyltin compounds,{[C6H5O(O)C=N-N=C(Ph)COO](m-Cl-C6H4CH2)2-Sn(CH3OH)}2(1)and{[p-Me-C6H4O(O)C=N-N=C(Ph)COO](m-Cl-C6H4CH2)2Sn(CH3OH)}2(2),have been synthesized by microwave“one pot”reaction with benzoylhydrazine(or p-methyl benzhydrazine),phenylglyoxylic acid and di-m-chlorobenzyltin dichloride.Compound 2 contains two crystals 2a and 2b.The compounds have been characterized with IR,elemental analysis,1H,13C and 119Sn NMR spectra,H RMS.Three crystals are all binuclear molecules with a Sn2O2 four-membered ring plane,and each Sn atom center is seven-coordinated with[SnO4C2N]to form a distorted pentagonal bipyramidal configuration.In vitro antitumor activities of all compounds and carboplatin were evaluated by MTT against three human cancer cells such as NCI-H460(lung cancer cells),HepG2(liver cancer cells)and MCF7(breast cancer cells),and compound 2 exhibited better antitumor activity.
基金Supported by Hengyang Normal University College Students Scientific and Technological Works Project (No. 167 and 168)Foundation of Key Laboratory of Functional Organometallic Materials,University of Hunan Province (No. GN19K07)+1 种基金Scientific Research Fund of Hunan Provincial Education Department of China (No. 19C0279)Hengyang Normal University Industrial Supported Project (Nos. HXKJ201908,HXKJ201911,HXKJ201946 and HXKJ201947)。
文摘Diorganotin 2-(2-(4-methoxybenzoyl)hydrazono)-3-phenylpropanoic carboxylate complexes Ⅰ{[p-CH3 O-C6 H4 O(O)C=N-N=C(Ph CH2)COO](n-Bu)2 Sn(CH3 OH)}2 and Ⅱ {[p-CH3 O-C6 H4 O(O)C=NN=C(Ph CH2)COO](Ph CH2)2 Sn(CH3 OH)}2 have been synthesized. The complexes have been characterized by IR, 1 H, 13 C and 119 Sn NMR spectra, HRMS, elemental analysis, thermal stability analysis and the crystal structures have been determined by X-ray diffraction. The crystal of complex I belongs to triclinic system, space group P1 with a = 10.437(2), b = 11.576(3), c = 13.085(3) ?, α = 66.272(2)°, β = 86.920(3)°, γ = 73.367(3)°, Z = 2, V = 1383.3(5) ?3, Dc = 1.381 Mg·m-3, m(Mo Kα) = 0.959 mm-1, F(000) = 592, R = 0.0233 and w R = 0.0644. The crystal of complex Ⅱ is of triclinic system, space group P1 with a = 10.446(1), b = 11.720(1), c = 13.063(2) ?, α = 84.190(1)°, β = 71.610(1)°, γ = 72.624(1)°, Z = 1, V = 1448.3(3) ?3, Dc = 1.475 Mg·m-3, m(Mo Kα) = 0.925 mm-1, F(000) = 656, R = 0.0169 and w R = 0.0432. In vitro antitumor activities of both complexes were evaluated by MTT against three human cancer cell lines(NCI-H460, Hep G2 and MCF7), and two complexes exhibited good antitumor activity. The interaction between complex Ⅰ and calf thymus DNA were studied by UV-vis and fluorescence spectroscopy, the interaction of complex Ⅰ with calf thymus DNA were intercalation.
基金Supported by the Scientific Research Fund of Hunan Provincial Education Department of China (No. 19C0279)Functional Metal-organic Compounds of Hunan Science and Technology Innovation Team
文摘Schiff base pyridine zinc(II)complexes 1~4 were synthesized by the reaction of the 2-((2-hydroxybenzylidene)amino)phenol Schiff base with appended donor functionality,zinc acetate,and pyridine.The results of the structural characterization of the complex show that they have the same coordination mode and similar steric structure.Complexes 1 and 3 form a one-dimensional chain structure and two-dimensional grid struc-ture by lots of hydrogen bonds,respectively.Thermogravimetric analysis shows complexes 1~4 can exist stably be-low 150℃.The results of the fluorescence quenching experiments between the complexes and DNA-EB show that the interaction between them is intercalation,and the effect of complex 1 is the most obvious.It is speculated that the steric hindrance of complex 1 is relatively small,and the aromatic ring on the ligand is more likely to inserted into the base pair of DNA.
基金Supported by the Scientific Research Fund of Hunan Provincial Education Department of China(No.19C0279)Functional Metal-organic Compounds of Hunan Science and Technology Innovation Team。
文摘Dibutyltin benzoin benzoyl hydrazone complex Ⅰ[C_(6)H_(5)(O)C=N-N=C(Ph)CH(Ph)O]_(2)[(n-Bu)_(2)Sn]_(2)and dibutyltin benzoin salicyl hydrazone complex Ⅱ[2-(OH)-C_(6)H_(4)(O)C=N-N=C(Ph)CH(Ph)O]_(2)[(n-Bu)_(2)Sn]_(2)were synthesized and characterized by IR,^(1)H,^(13)C and^(119)Sn NMR spectra,HRMS,elemental analysis and thermal stability analysis,and the crystal structures were determined by X-ray diffraction.The crystal of complex I belongs to monoclinic system,space group P2_(1)/n with a=11.1942(8),b=10.4754(7),c=23.6700(17)?,?=101.529(2)?,Z=2,V=2719.6(3)?^(3),D_(c)=1.371 Mg·m^(–3),?(Mo Kα)=0.966 mm^(–1),F(000)=1152,R=0.0458and w R=0.1312.The crystal of complex II is of triclinic system,space group P1 with a=9.9960(4),b=11.2466(4),c=14.0509(5)?,α=69.4190(10)?,?=70.0600(10)?,γ=81.8090(10)?,Z=1,V=1389.69(9)?^(3),D_(c)=1.380 Mg·m^(–3),?(Mo Kα)=0.950 mm^(–1),F(000)=592,R=0.0284 and w R=0.0690.In vitro antitumor activities of both complexes were evaluated by CCK8 method against three human cancer cell lines(MCF7,NCI-H460 and Hep G2),and complex II exhibited better antitumor activity than I.The interaction between complexes and calf thymus DNA was studied by UV-vis,fluorescence spectroscopy and viscosity measurements.
基金the Natural Science Foundation of Hunan Province(No.2020JJ8096)。
文摘Di-2,4-dichlorobenzyltin-2-(2-(thiophen-2-formyl)hydrazono)-propanoic carboxylate complex I{[C_(4)H_(3)S(O)C=N-N=C(CH_(3))COO]_(2)[(2,4-Cl_(2)-C_(6)H_(3)CH_(2))_(2)Sn]_(2)(CH_(3)OH)_(2)}and di-2,4-dichlorobenzyltin-2-(2-(thio-phen-2-formyl)hydrazono)-3-phenylpropanoic carboxylate complexⅡ{[C_(4)H_(3)S(O)C=N-N=C(PhCH_(2))COO](2,4-Cl_(2)-C_(6)H_(3)CH_(2))_(2)Sn}n were synthesized and characterized by IR,^(1)H,^(13)C and^(119)Sn NMR spectra,HRMS,elemental analysis and thermal stability analysis,and the crystal structures were determined by X-ray diffraction.The crystal of complex I belongs to monoclinic system,space group P2_(1/n)with a=11.987(3),b=35.359(9),c=12.982(3)Å,β=103.028(5)°,Z=4,V=5361(2)Å3,Dc=1.688 Mg·m^(–3),μ(MoKα)=1.463 mm^(–1),F(000)=2704,R=0.0572 and wR=0.1423.The crystal of complexⅡis of monoclinic system,space group P2_(1/n)with a=15.5758(17),b=9.6020(10),c=19.599(2)Å,β=98.886(2)°,Z=4,V=2896.0(5)Å3,Dc=1.663 Mg·m^(–3),μ(MoKα)=1.357 mm^(–1),F(000)=1440,R=0.0341 and wR=0.0936.In vitro antitumor activities of both complexes were evaluated by MTT against three human cancer cell lines(MCF7,NCI-H460 and HepG2),and they all exhibited good antitumor activity.The interaction between complexes and calf thymus DNA was studied by UV-vis and fluorescence spectroscopy,it indicated intercalation as probable mode of interaction.
基金Supported by the Foundation of Hunan Provincial Engineering Research Center for Uranium Exploration Technology(No.YK20K03)。
文摘Two U0^(2+)_(2) complexes{[C_(5)H_(4)N(0)C=N-N=C(PhHPh)C=N-N=C(0)-C_(5)H_(4)N]2U02(CH30H)}(I)and{[C_(5)H_(4)N(0)ON-N=C(Ph)-(Ph)C=N-N=C(0)-C_(5)H_(4)N]2U02(C_(5)H_(4)N(0)C=N-NH_(2))}(II)were synthesized and characterized by IR,elemental analysis and thermal stability analysis,and the crystal structures were determined by X-ray diffraction.The crystal of complex I belongs to monoclinic system,space group P2_(1/n) with α=11.7678(4),6=16.9667(6),c=14.3051(5)A,β=98.918(3)°,Z=4,F=2821.64(17)A^(3),D_(c)=1.837 Mg·m^(-3),μ(MoKα)=5.805 mm^(-1),F(000)=1504,R=0.0346 and wR=0.0688.The crystal of complex II is of triclinic system,space group Pi with a=11.6417(5),b=11.7297(5),c=14.2197(5)A,α=71.697(4)°,β=86.020(3)°,γ=71.572(4)°,Z=2,K=1748.02(12)A^(3),D_(c)=1.742 Mg·m^(-3),μ(MoKa)=4.704 mm^(-1),F(000)=894,R=0.0283 and wR=0.0537.The U1 is a seven-coordinate pentagonal bipyramidal configuration in I and an eight-coordinate hexagonal dipyramidal configuration in II.The thermal stability and quantum chemical calculations of I and II were also investigated.